Merck / Bio E required support and expertise for the fit-out of a new pharmaceutical manufacturing suite within an existing building.
The Challenge
Working within the challenging site constraints of an existing facility, specialist engineering strategies were required to meet the complex design and construction requirements of a pharmaceutical suite to manufacture conjugated vaccines in a production environment compliant with the requirements of the United States Food and Drug Administration (FDA).
Synertec's Solution
Synertec provided resources for project management, construction management, commissioning, and qualification services to deliver the design, procurement, construction, and validation of a new suite for the manufacture of conjugated vaccines to meet FDA compliance and approval.
The new facility, with full High Efficiency Particulate Air (HEPA) filtration and containment zones for fume control, incorporated the following main processes:
Preparation and washing: glass washer
Sterilisation: autoclave
Dissolution and homogenisation: glass vessels and homogeniser
The process used mobile vessels and skids with mobile Clean In Place (CIP) and Sterilisation In Place (SIP) skids for cleaning and sanitisation. All new purified water, Water For Injection (WFI) and clean steam skids and distribution systems were also part of the project scope. Infrastructure upgrades included new chillers, along with a new transformer and associated electrical switch gear.